Home Pulmotect

Pulmotect

In operation
Series B
Biopharmaceutical Company

Basic Information

Pulmotect is a biopharmaceutical company that develops products to enhance the innate immune system for the prevention of various lung infections. Its technology stimulates the body's natural defense system, providing safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Category A bioterrorism agents (including anthrax, tularemia, and plague).
Pulmotect, Inc.
Houston,Texas,United States of America
less than 15 people
January 01, 2007
nmolfino@pulmotect.com